Anna Ermacora

818 total citations
27 papers, 579 citations indexed

About

Anna Ermacora is a scholar working on Oncology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anna Ermacora has authored 27 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anna Ermacora's work include Drug Transport and Resistance Mechanisms (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hepatitis C virus research (6 papers). Anna Ermacora is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hepatitis C virus research (6 papers). Anna Ermacora collaborates with scholars based in Italy, Netherlands and Ukraine. Anna Ermacora's co-authors include Michele Baccarani, Mariagrazia Michieli, Daniela Damiani, Paola Masolini, Angela Michelutti, Domenico Russo, Donatella Raspadori, Renato Fanin, Giuseppe Visani and R.J. Scheper and has published in prestigious journals such as Blood, International Journal of Radiation Oncology*Biology*Physics and British Journal of Haematology.

In The Last Decade

Anna Ermacora

26 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Ermacora Italy 13 288 211 205 104 103 27 579
Entezam Sahovic United States 12 165 0.6× 157 0.7× 339 1.7× 41 0.4× 86 0.8× 30 613
Radovan Sašo United Kingdom 22 384 1.3× 278 1.3× 846 4.1× 105 1.0× 73 0.7× 50 1.2k
Ted Gooley United States 9 123 0.4× 53 0.3× 419 2.0× 94 0.9× 86 0.8× 15 614
Jurjen Versluis Netherlands 13 305 1.1× 120 0.6× 240 1.2× 82 0.8× 48 0.5× 43 747
Sam Penza United States 17 321 1.1× 103 0.5× 467 2.3× 134 1.3× 47 0.5× 63 806
Peter Waldron United States 13 117 0.4× 155 0.7× 169 0.8× 49 0.5× 91 0.9× 30 641
R Leblay France 9 294 1.0× 269 1.3× 229 1.1× 161 1.5× 73 0.7× 31 832
Laura Bellio Italy 10 186 0.6× 66 0.3× 203 1.0× 53 0.5× 58 0.6× 15 508
J.P. Laporte France 12 207 0.7× 60 0.3× 272 1.3× 58 0.6× 40 0.4× 32 574
Seung‐Hwan Shin South Korea 18 205 0.7× 162 0.8× 570 2.8× 169 1.6× 51 0.5× 68 777

Countries citing papers authored by Anna Ermacora

Since Specialization
Citations

This map shows the geographic impact of Anna Ermacora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ermacora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ermacora more than expected).

Fields of papers citing papers by Anna Ermacora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ermacora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ermacora. The network helps show where Anna Ermacora may publish in the future.

Co-authorship network of co-authors of Anna Ermacora

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ermacora. A scholar is included among the top collaborators of Anna Ermacora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ermacora. Anna Ermacora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazzaro, Cesare, Luigino Dal Maso, Marcella Visentini, et al.. (2021). Hepatitis C virus‐associated indolent B‐cell lymphomas: A review on the role of the new direct antiviral agents therapy. Hematological Oncology. 39(4). 439–447. 3 indexed citations
2.
Mazzaro, Cesare, Endri Mauro, Anna Ermacora, et al.. (2021). Hepatitis C virus-related cryoglobulinemic vasculitis. Minerva Medica. 112(2). 175–187. 5 indexed citations
3.
Grembiale, Alessandro, et al.. (2020). An Unusual Case of Cholestatic Hepatitis due to Light-Chain Deposition Disease. Case Reports in Oncology. 13(3). 1343–1348. 4 indexed citations
4.
Mazzaro, Cesare, Luigino Dal Maso, Marcella Visentini, et al.. (2020). Recent news in the treatment of hepatitis B virus-related cryogobulinemic vasculitis. Minerva Medica. 111(6). 566–572. 4 indexed citations
5.
Toffoletti, Eleonora, Massimiliano Bonifacio, Gianni Binotto, et al.. (2020). BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC". Blood. 136(Supplement 1). 9–10. 1 indexed citations
6.
7.
Filì, Carla, Anna Candoni, Maria Elena Zannier, et al.. (2018). Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience. Leukemia Research. 76. 33–38. 26 indexed citations
8.
Furlan, Carlo, Vincenzo Canzonieri, Michele Spina, et al.. (2016). Low‐dose radiotherapy in diffuse large B‐cell lymphoma. Hematological Oncology. 35(4). 472–479. 11 indexed citations
9.
Damiani, Daniela, Angela Michelutti, Mariagrazia Michieli, et al.. (2002). P‐glycoprotein, lung resistance‐related protein and multidrug resistance‐associated protein in de novo adult acute lymphoblastic leukaemia. British Journal of Haematology. 116(3). 519–527. 31 indexed citations
10.
Michieli, Mariagrazia, Angela Michelutti, Daniela Damiani, et al.. (2001). Amifostine Does Not Inhibit the Toxic Effects of Anthracycline Derivates or Mitoxantrone on MDR Tumor Cell Lines. Leukemia & lymphoma. 42(4). 721–729. 2 indexed citations
11.
Michieli, Mariagrazia, Daniela Damiani, Anna Ermacora, et al.. (2000). P‐glycoprotein (PGP), lung resistance‐related protein (LRP) and multidrug resistance‐associated protein (MRP) expression in acute promyelocytic leukaemia. British Journal of Haematology. 108(4). 703–709. 37 indexed citations
12.
Pea, Federico, Domenico Russo, Mariagrazia Michieli, et al.. (2000). Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia. Cancer Chemotherapy and Pharmacology. 46(4). 279–286. 23 indexed citations
13.
Donini, Annibale, Umberto Baccarani, Giovanni Terrosu, et al.. (1999). Laparoscopic vs open splenectomy in the management of hematologic diseases. Surgical Endoscopy. 13(12). 1220–1225. 74 indexed citations
14.
Michieli, Mariagrazia, Daniela Damiani, Anna Ermacora, et al.. (1999). Liposome‐encapsulated daunorubicin for PGP‐related multidrug resistance. British Journal of Haematology. 106(1). 92–99. 43 indexed citations
15.
Michieli, Mariagrazia, Daniela Damiani, Anna Ermacora, et al.. (1999). P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications. British Journal of Haematology. 104(2). 328–335. 99 indexed citations
16.
Pea, Federico, Daniela Damiani, Mariagrazia Michieli, et al.. (1999). Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. European Journal of Clinical Pharmacology. 55(5). 361–368. 15 indexed citations
17.
Zaja, Francesco, et al.. (1999). Rituximab for the treatment of type II mixed cryoglobulinemia.. PubMed. 84(12). 1157–8. 41 indexed citations
18.
Damiani, Daniela, Mariagrazia Michieli, Anna Ermacora, et al.. (1998). P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.. PubMed. 83(4). 290–7. 30 indexed citations
19.
Damiani, Daniela, Mariagrazia Michieli, Anna Ermacora, et al.. (1998). Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. Leukemia. 12(8). 1236–1240. 18 indexed citations
20.
Michieli, Mariagrazia, Daniela Damiani, Anna Ermacora, et al.. (1997). P‐glycoprotein (PGP) and lung resistance‐related protein (LRP) expression and function in leukaemic blast cells. British Journal of Haematology. 96(2). 356–365. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Entezam Sahovic Breakdown of academic impact, for papers by Radovan Sašo Breakdown of academic impact, for papers by Ted Gooley Breakdown of academic impact, for papers by Jurjen Versluis Breakdown of academic impact, for papers by Sam Penza Breakdown of academic impact, for papers by Peter Waldron Breakdown of academic impact, for papers by R Leblay Breakdown of academic impact, for papers by Laura Bellio Breakdown of academic impact, for papers by J.P. Laporte Breakdown of academic impact, for papers by Seung‐Hwan Shin
Rankless by CCL
2026